143 related articles for article (PubMed ID: 20039217)
1. The evolving role of taurolidine in cancer therapy.
Neary PM; Hallihan P; Wang JH; Pfirrmann RW; Bouchier-Hayes DJ; Redmond HP
Ann Surg Oncol; 2010 Apr; 17(4):1135-43. PubMed ID: 20039217
[TBL] [Abstract][Full Text] [Related]
2. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
3. Treatment of glioblastoma with intravenous taurolidine. First clinical experience.
Stendel R; Picht T; Schilling A; Heidenreich J; Loddenkemper C; Jänisch W; Brock M
Anticancer Res; 2004; 24(2C):1143-7. PubMed ID: 15154639
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
5. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
6. Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review).
Möhler H; Pfirrmann RW; Frei K
Int J Oncol; 2014 Oct; 45(4):1329-36. PubMed ID: 25175943
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
[TBL] [Abstract][Full Text] [Related]
8. Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine.
Härtel C; Scholz T; Kuhn M; Bendiks M; Göpel W; Lauten M; Herting E
J Microbiol Immunol Infect; 2013 Apr; 46(2):115-20. PubMed ID: 22727544
[TBL] [Abstract][Full Text] [Related]
9. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
[TBL] [Abstract][Full Text] [Related]
10. Taurolidine in the prevention and therapy of lung metastases.
Hoksch B; Rufer B; Gazdhar A; Bilici M; Beshay M; Gugger M; Schmid RA
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1058-63. PubMed ID: 19850492
[TBL] [Abstract][Full Text] [Related]
11. Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma.
Aceto N; Bertino P; Barbone D; Tassi G; Manzo L; Porta C; Mutti L; Gaudino G
Eur Respir J; 2009 Dec; 34(6):1399-407. PubMed ID: 19460788
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
14. Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
Opitz I; Van der Veen H; Witte N; Braumann C; Mueller JM; Jacobi CA
Eur Surg Res; 2007; 39(3):129-35. PubMed ID: 17337889
[TBL] [Abstract][Full Text] [Related]
15. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
Koldehoff M; Zakrzewski JL
Int J Antimicrob Agents; 2004 Nov; 24(5):491-5. PubMed ID: 15519483
[TBL] [Abstract][Full Text] [Related]
16. Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
Stendel R; Scheurer L; Schlatterer K; Gminski R; Möhler H
Anticancer Res; 2004; 24(2B):631-8. PubMed ID: 15161005
[TBL] [Abstract][Full Text] [Related]
17. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Braumann C; Schoenbeck M; Menenakos C; Kilian M; Jacobi CA
Clin Exp Metastasis; 2005; 22(1):77-83. PubMed ID: 16132581
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
Stendel R; Scheurer L; Schlatterer K; Stalder U; Pfirrmann RW; Fiss I; Möhler H; Bigler L
Clin Pharmacokinet; 2007; 46(6):513-24. PubMed ID: 17518510
[TBL] [Abstract][Full Text] [Related]
19. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid/carboxymethylcellulose membrane barrier versus taurolidine for the prevention of adhesions to polypropylene mesh.
Erpek H; Tuncyurek P; Soyder A; Boylu S
Eur Surg Res; 2006; 38(4):414-7. PubMed ID: 16874004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
